D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ABMD holding history
Abiomed Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABMD overviewAll 13F holders of ABMDFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −3,448−100.0% | Sold out | Holders |
| Q3 2022 | 3,448 | $847.0K | <0.1% | −327−8.7% | Reduced | Holders |
| Q2 2022 | 3,775 | $934.0K | <0.1% | +2,025+115.7% | Added | Holders |
| Q1 2022 | 1,750 | $580.0K | <0.1% | +119+7.3% | Added | Holders |
| Q4 2021 | 1,631 | $586.0K | <0.1% | +200+14.0% | Added | Holders |
| Q3 2021 | 1,431 | $466.0K | <0.1% | +400+38.8% | Added | Holders |
| Q2 2021 | 1,031 | $322.0K | <0.1% | −1,237−54.5% | Reduced | Holders |
| Q1 2021 | 2,268 | $722.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.